WARS2 and neoplasm: Collectively, these results confirm that WARS2 promotes LUAD progression by enhancing tumor cell proliferation and invasion, sustaining mitochondrial oxidative metabolism, and fostering an immune-suppressive microenvironment that favors tumor growth.